Vanda Pharmaceuticals
Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.
-
One-Patient trial hopes to fix genetic error causing rare nerve disease
Disease control OngoingThis study tests a new drug called VCA-894A in a single person with a rare, inherited nerve disease (CMT2S) caused by a specific genetic mutation. The drug is designed to correct the genetic error and restore the missing protein. The main goals are to see if the treatment is safe…
Phase: PHASE1, PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New topical treatment shows promise for stubborn nail fungus
Disease control OngoingThis study tests a new topical solution (VTR-297) for mild to severe toenail fungus. About 50 adults will apply the solution daily for 4 weeks. Researchers will check safety and whether the fungus clears using lab tests. The goal is to find a better treatment option for this comm…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New motion sickness pill could make travel easier for millions
Symptom relief OngoingThis study tests a drug called tradipitant to see if it safely reduces motion sickness symptoms like nausea and vomiting during travel. 705 adults with a history of motion sickness took the drug and were monitored for side effects. The goal is to provide a new option for people w…
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 05:43 UTC